Adam Cuker, MD, MS is board-certified in internal medicine and hematology and a fellow of the American College of Physicians at the Hospital of the University of Pennsylvania.
Adam earned his Bachelor of Science degree in Biological Sciences from Cornell University in 1998 and attended Yale University School of Medicine where he received his Doctor of Medicine degree in 2003. After completion of his doctorate degree, Adam went on to complete an internship and residency in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. He continued his postgraduate training at the Hospital of the University of Pennsylvania where he was a fellow in hematology/oncology. In addition to his Medical Degree, Adam holds a Master’s of Science degree in Translational Research from the University of Pennsylvania.
He is an Assistant Professor of Medicine and Pathology & Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine. Additionally, Adam serves as Director of the Penn Comprehensive Hemophilia and Thrombosis Program, Associate Director of Clinical Research of the Penn-CHOP Blood Center for Patient Care and Discovery and Assistant Director of the Penn Specialized Coagulation Laboratory.
In addition to conducting National Institutes of Health (NIH)-funded research on heparin-induced thrombocytopenia, immune thrombocytopenia, venous thromboembolism, and anticoagulation, Adam serves as a member and Chair of several organizations and panels. Adam is a member of the American Society of Hematology (ASH), Chair of the ASH Venous Thromboembolism Guideline Coordination Panel as well as the Chair of the ASH panel on heparin-induced thrombocytopenia. He serves on the Board of Directors of the Anticoagulation Forum and the Hemostasis & Thrombosis Research Society, is a member of the International Society on Thrombosis and Haemostasis and a fellow of the American College of Physicians.
At Synergy Research, Adam holds the position of Safety Monitor for various programs and Sponsors. As a Safety Monitor, he is responsible for safety oversight of ongoing clinical trials, continuous review of subject safety data, review of subject narratives, and causality review with the Sponsor, if necessary. Additionally, Adam is a voting member of the PADDOCK Safety Monitoring Committee.